Kbi Biopharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Kbi Biopharma

Access the complete profile.

Kbi Biopharma Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	P.o. Box 15579 Durham, NC 27704

Note: Revenues for privately held companies are statistical evaluations.


Kbi Biopharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Kbi Biopharma's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Kbi Biopharma is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Kbi Biopharma Annual Revenue and Growth Rate

Kbi Biopharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Kbi Biopharma's revenues are gauged from an analysis of company filings.

Kbi Biopharma's Income Statement (based on Industry Averages)

Kbi Biopharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Kbi Biopharma is developing and marketing. Kbi Biopharma's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SUREMAB Biotechnology research and development services for others, namely, mammalian cell line development, monoclonal antibody development, genome sequencing, genome mapping, genome and nucleic acid analysis, genome amplification, genome scanning, and high performance computing services for genome sequencing	12/27/2023
SURETECHNOLOGY PLATFORM Biotechnology research and development services for others, namely, mammalian cell line development, monoclonal antibody development, genome sequencing, genome mapping, genome and nucleic acid analysis, genome amplification, genome scanning, and high performance computing services for genome sequencing	12/27/2023
SURESTATION Biotechnology research and development services for others, namely, mammalian cell line development, monoclonal antibody development, genome sequencing, genome mapping, genome and nucleic acid analysis, genome amplification, genome scanning, and high performance computing services for genome sequencing	12/27/2023

See all trademarks and details in the Full Report.

Market Share of Kbi Biopharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Kbi Biopharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Kbi Biopharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
RESEARCH TRIANGLE INSTITUTE INTERNATIONAL	Durham, NC	100
KBI BIOPHARMA	Durham, NC	89
VELOCITY CLINICAL RESEARCH	Durham, NC	43
FAMILY HEALTH INTERNATIONAL	Durham, NC	37
WORLDWIDE CLINICAL TRIALS	Durham, NC	37
BIOAGILYTIX LABS LLC.	Durham, NC	26

Future Competition: Kbi Biopharma's Fastest Growing Competitors

These companies are in the same general field as Kbi Biopharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)